Skip to main content
. 2018 Jan 4;15(3):3548–3551. doi: 10.3892/ol.2018.7730

Figure 3.

Figure 3.

Detection of effects of NOB1 expression and osteosarcoma cells on the sensitivity to cisplatin by CCK-8. IC50: si-NOB1 vs. si-control = 12.23±2.74 vs. 26.67±3.86; **p<0.01. IC50: si-NOB1 vs. si-control, 12.23±2.74 vs. 26.67±3.86; **p<0.01. NOB1, NIN1/RPN12 binding protein 1 homolog; IC50, inhibitory concentration.